BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15726655)

  • 1. The human liver clears both asymmetric and symmetric dimethylarginine.
    Siroen MP; van der Sijp JR; Teerlink T; van Schaik C; Nijveldt RJ; van Leeuwen PA
    Hepatology; 2005 Mar; 41(3):559-65. PubMed ID: 15726655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia.
    Nijveldt RJ; Siroen MP; Teerlink T; van Lambalgen AA; Rauwerda JA; van Leeuwen PA
    Liver Int; 2004 Oct; 24(5):510-8. PubMed ID: 15482350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).
    Nijveldt RJ; Teerlink T; Siroen MP; van Lambalgen AA; Rauwerda JA; van Leeuwen PA
    Clin Nutr; 2003 Feb; 22(1):17-22. PubMed ID: 12553945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia.
    Nijveldt RJ; Teerlink T; van Guldener C; Prins HA; van Lambalgen AA; Stehouwer CD; Rauwerda JA; van Leeuwen PA
    Nephrol Dial Transplant; 2003 Dec; 18(12):2542-50. PubMed ID: 14605276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease.
    Bode-Böger SM; Scalera F; Kielstein JT; Martens-Lobenhoffer J; Breithardt G; Fobker M; Reinecke H
    J Am Soc Nephrol; 2006 Apr; 17(4):1128-34. PubMed ID: 16481412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects.
    Paroni R; Fermo I; Fiorina P; Cighetti G
    Amino Acids; 2005 Jun; 28(4):389-94. PubMed ID: 15827687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).
    Tain YL; Hsu CN
    Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28272322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans.
    Nijveldt RJ; Van Leeuwen PA; Van Guldener C; Stehouwer CD; Rauwerda JA; Teerlink T
    Nephrol Dial Transplant; 2002 Nov; 17(11):1999-2002. PubMed ID: 12401860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
    Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress.
    Cighetti G; Fermo I; Aman CS; Ferraroni M; Secchi A; Fiorina P; Paroni R
    Free Radic Biol Med; 2009 Aug; 47(3):307-11. PubMed ID: 19446631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of symmetric dimethylarginine in hepatorenal syndrome.
    Lluch P; Mauricio MD; Vila JM; Segarra G; Medina P; Del Olmo JA; Rodrigo JM; Serra MA
    Exp Biol Med (Maywood); 2006 Jan; 231(1):70-5. PubMed ID: 16380646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of asymmetric and symmetric dimethylarginines in renal disease.
    Schwedhelm E; Böger RH
    Nat Rev Nephrol; 2011 May; 7(5):275-85. PubMed ID: 21445101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach.
    Oliva-Damaso E; Oliva-Damaso N; Rodriguez-Esparragon F; Payan J; Baamonde-Laborda E; Gonzalez-Cabrera F; Santana-Estupiñan R; Rodriguez-Perez JC
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human taurine metabolism: fluxes and fractional extraction rates of the gut, liver, and kidneys.
    van Stijn MF; Vermeulen MA; Siroen MP; Wong LN; van den Tol MP; Ligthart-Melis GC; Houdijk AP; van Leeuwen PA
    Metabolism; 2012 Jul; 61(7):1036-40. PubMed ID: 22304837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.
    Mittermayer F; Kautzky-Willer A; Winzer C; Krzyzanowska K; Prikoszovich T; Demehri S; Wagner O; Wolzt M
    J Intern Med; 2007 Apr; 261(4):392-8. PubMed ID: 17391114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
    Krzyzanowska K; Mittermayer F; Shnawa N; Hofer M; Schnabler J; Etmüller Y; Kapiotis S; Wolzt M; Schernthaner G
    Diabet Med; 2007 Jan; 24(1):81-6. PubMed ID: 17227328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA.
    Bulau P; Zakrzewicz D; Kitowska K; Leiper J; Gunther A; Grimminger F; Eickelberg O
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L18-24. PubMed ID: 16891395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients.
    Siroen MP; Wiest R; Richir MC; Teerlink T; Rauwerda JA; Drescher FT; Zorger N; van Leeuwen PA
    World J Gastroenterol; 2008 Dec; 14(47):7214-9. PubMed ID: 19084936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.